Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
Using human sera having antibodies against Epstein-Barr virus (EBV) early antigens (EA) but lacking antibodies directed against the EB nuclear antigen (EBNA), the detection of EBV/EA was possible both by the anticomplement immunofluorescent test (ACIF) and by the classical complement fixation test (CF). The latter is particularly suitable for biochemical studies on EA.